Literature DB >> 17303252

Role of glutamate on T-cell mediated immunity.

Rodrigo Pacheco1, Teresa Gallart, Carmen Lluis, Rafael Franco.   

Abstract

The pivotal role that glutamate plays in the functioning of the central nervous system is well established. Several glutamate receptors and glutamate transporters have been extensively described in the central nervous system where they, respectively mediate glutamate effects and regulates extracellular glutamate levels. Recent studies have shown that glutamate not only has a role as neurotransmitter, but also as an important immunomodulator. In this regard, several glutamate receptors have recently been described on the T-cell surface, whereas glutamate transporters have reportedly been expressed in antigen presenting cells such as dendritic cells and macrophages. On the other hand, an increasing number of reports have described a protective autoimmune mechanism in which autoantigen specific T cells in the central nervous system protect neurons against glutamate neurotoxicity. This review integrates and summarises different findings in this emerging area. A role of glutamate as a key immunomodulator in the initiation and development of T-cell-mediated immunity in peripheral tissues as well as in the central nervous system is suggested.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17303252     DOI: 10.1016/j.jneuroim.2007.01.003

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  58 in total

Review 1.  Immune dysfunction in autism: a pathway to treatment.

Authors:  Milo Careaga; Judy Van de Water; Paul Ashwood
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

2.  Statins, regulatory T cells and amyotrophic lateral sclerosis.

Authors:  Mark R Goldstein; Luca Mascitelli; Francesca Pezzetta
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 3.  Antineuronal antibodies against neurotransmitter receptors and synaptic proteins in schizophrenia: current knowledge and clinical implications.

Authors:  Johann Steiner; Kolja Schiltz; Hans-Gert Bernstein; Bernhard Bogerts
Journal:  CNS Drugs       Date:  2015-03       Impact factor: 5.749

Review 4.  Some cross-talks between immune cells and epilepsy should not be forgotten.

Authors:  Hong Wang; Sibo Liu; Zeyao Tang; Jinjie Liu
Journal:  Neurol Sci       Date:  2014-09-25       Impact factor: 3.307

5.  System xc⁻ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS.

Authors:  Richard J Bridges; Nicholas R Natale; Sarjubhai A Patel
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

Review 6.  Interlinking interleukin-7.

Authors:  Christina Kittipatarin; Annette R Khaled
Journal:  Cytokine       Date:  2007-09-04       Impact factor: 3.861

Review 7.  The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells.

Authors:  Yonatan Ganor; Mia Levite
Journal:  J Neural Transm (Vienna)       Date:  2014-03-02       Impact factor: 3.575

Review 8.  The role of glutamate and the immune system in organophosphate-induced CNS damage.

Authors:  Arik Eisenkraft; Avshalom Falk; Arseny Finkelstein
Journal:  Neurotox Res       Date:  2013-03-27       Impact factor: 3.911

9.  Protection from fatal viral encephalomyelitis: AMPA receptor antagonists have a direct effect on the inflammatory response to infection.

Authors:  Ivorlyne P Greene; Eun-Young Lee; Natalie Prow; Brownhilda Ngwang; Diane E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-22       Impact factor: 11.205

10.  Intensive Rehabilitation Enhances Lymphocyte BDNF-TrkB Signaling in Patients With Parkinson's Disease.

Authors:  Cecilia Fontanesi; Svetlana Kvint; Giuseppe Frazzitta; Rossana Bera; Davide Ferrazzoli; Alessandro Di Rocco; Heike Rebholz; Eitan Friedman; Gianni Pezzoli; Angelo Quartarone; Hoau-Yan Wang; M Felice Ghilardi
Journal:  Neurorehabil Neural Repair       Date:  2015-08-07       Impact factor: 3.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.